Bethlehem is a Teaching Fellow in Public Health and PhD candidate in the Department of Epidemiology and Biostatistics in the School of Public Health.
Bethlehem's PhD aims to define and measure housing quality and quantify the health impact of housing policies in London.
Before becoming a Teaching Fellow at the School of Public Health, Bethlehem worked as a Research Assistant in Urban Health/Research Associate in Population Health within the the Global Environmental Health Research Group.
Prior to joining Imperial, Bethlehem was an Associate Epidemiologist at Decision Resources Group, where she developed epidemiology-based disease forecasts and provided support for various oncology indications, including renal cell carcinoma, malignant melanoma, and breast cancer for bio-pharmaceutical clients.
Previously, Bethlehem interned at the University of Cambridge/Wellcome Trust Sanger Institute, where she participated in the design and implementation of various epidemiological studies focusing on non-communicable diseases, particularly in the developing world.
Bethlehem holds an MPH with concentrations in Epidemiology and Global Health from Boston University and holds a BA in Health: Science, Society, and Policy and Education Studies from Brandeis University.
Doyle YG, Solomon BD, Owusu G, 2022, Cities and global health: fragmented housing policies increase health risks for vulnerable people., Bmj, Vol:379, ISSN:1759-2151, Pages:1-4
et al., 2022, Synthesizing the links between secure housing tenure and health for more equitable cities, Wellcome Open Research, Vol:7, Pages:18-18
NCD Risk Factor Collaboration (NCD-RisC), Iurilli N, 2021, Heterogeneous contributions of change in population distribution of body-mass index to change in obesity and underweight, Elife, Vol:10, ISSN:2050-084X
Osibona O, Solomon B, Fecht D, 2021, Lighting in the home and health: a systematic review, International Journal of Environmental Research and Public Health, Vol:18, ISSN:1660-4601
et al., 2021, Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants, The Lancet, Vol:398, ISSN:0140-6736, Pages:957-980